SAEN — Genenta Science S.p.A.
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1838716 ·
Last close
$0.58
Market Cap
$27.82M
52W High
$2.58
52W Low
$0.55
ADV30
114,649
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 31,889,310 | 5,527,672 | 10,048,670 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-62,585,347
Inventory
—
Receivables
$1,285,630
ST Investments
$22,621,518
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -6,603,740 | -6,529,827 | 31,889,310 | 10,048,670 | 21,840,640 | -6,867,959 |
| Dec 2024 | 0 | -9,764,310 | -8,912,495 | 14,823,993 | 2,328,287 | 12,495,706 | -6,240,174 |
| Dec 2023 | 0 | -11,732,942 | -11,645,455 | 22,347,145 | 1,914,888 | 20,432,257 | -11,205,023 |
| Dec 2022 | 0 | -11,043,992 | -8,477,763 | 33,437,860 | 2,299,694 | 31,138,166 | -7,418,236 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| PTHS | Pelthos Therapeutics Inc. | $26.89M | $6.84 | — |
| INMB | Inmune Bio, Inc. | $29.72M | $0.96 | — |
| LONA | LeonaBio, Inc. | $26.00M | $2.76 | — |
| EXOZ | EXOZYMES INC. | $30.80M | $3.31 | — |
| EVAX | Evaxion A/S | $25.08M | $2.78 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.